000 01603 a2200457 4500
005 20250513235018.0
264 0 _c20010524
008 200105s 0 0 eng d
022 _a0003-4967
024 7 _a10.1136/ard.60.5.443
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSteen, K S
245 0 0 _aIncidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_cMay 2001
300 _a443-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aAnti-Ulcer Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xcomplications
650 0 4 _aCase-Control Studies
650 0 4 _aChi-Square Distribution
650 0 4 _aDuodenal Ulcer
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aIntestinal Perforation
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOdds Ratio
650 0 4 _aPeptic Ulcer Hemorrhage
_xchemically induced
650 0 4 _aRisk
650 0 4 _aStomach Ulcer
_xchemically induced
700 1 _aLems, W F
700 1 _aAertsen, J
700 1 _aBezemer, D
700 1 _aDijkmans, B A
773 0 _tAnnals of the rheumatic diseases
_gvol. 60
_gno. 5
_gp. 443-7
856 4 0 _uhttps://doi.org/10.1136/ard.60.5.443
_zAvailable from publisher's website
999 _c11237757
_d11237757